AZN
equitynet buyingAstraZeneca PLC · LONDON STOCK EXCHANGE
Buy it with play money
Fills at the latest stored close and lands in your paper portfolio
Sign in to buy AZN with $10,000 of play money and watch it from here.
Sign in to tradePrice, and when Congress traded it
Hollow marks where they traded, filled where the filing went public
Hover a marker to see who traded and what it was worth.
If you had bought it yourself
Paid at that day's close, held ever since. No member involved.
Working it out…
Short interest
Shares sold short, as brokers report them to FINRA twice a month
| Settlement date | Shares short | Change | Days to cover |
|---|---|---|---|
| Sep 30, 2026 | 2.62M | +25.4% | 0.9 |
| Sep 15, 2026 | 2.09M | -27.9% | 0.7 |
| Aug 31, 2026 | 2.9M | +53.0% | 0.9 |
| Aug 14, 2026 | 1.89M | +2.9% | 0.3 |
| Jul 31, 2026 | 1.84M | -27.4% | 0.7 |
| Jul 15, 2026 | 2.53M | +65.6% | 0.8 |
| Jun 30, 2026 | 1.53M | +15.3% | 0.8 |
| Jun 15, 2026 | 1.33M | -22.8% | 0.6 |
Largest fails to deliver, the last year
61 settlement days with at least $10,000 of shares sold and not delivered
| Settlement date | Shares | Value |
|---|---|---|
| Dec 16, 2025 | 505.35K | $46.3M |
| Jan 16, 2026 | 400.99K | $37.7M |
| Aug 31, 2026 | 185.23K | $30.1M |
| Dec 2, 2025 | 178.66K | $16.2M |
| Sep 4, 2026 | 64.88K | $10.7M |
Short interest is every broker's short position at the settlement date, reported to FINRA and published about a week and a half later; it does not say who is short. Days to cover is the short position over the average day's trading, and the share of the company is against the shares outstanding on its latest filing. A fail to deliver is the balance of shares sold and not delivered by settlement, from the SEC: it can be a short seller who never borrowed the stock, but is as often a late delivery that clears within days.
What they lobby on
Disclosed to the Senate, largest spend first
- ASTRAZENECA PHARMACEUTICALS LP$2.3M
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code, Copyright/Patent/Trademark, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)
1st Quarter (Jan 1 - Mar 31) 2026
- ASTRAZENECA PHARMACEUTICALS LP$1.7M
Health Issues, Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark, Tariff (miscellaneous tariff bills), Trade (domestic/foreign), Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code
2nd Quarter (Apr 1 - June 30) 2026
- W STRATEGIES, LLC$80K
Medicare/Medicaid
2nd Quarter (Apr 1 - June 30) 2026
- W STRATEGIES, LLC$80K
Medicare/Medicaid
1st Quarter (Jan 1 - Mar 31) 2026
- TARPLIN, DOWNS & YOUNG, LLC$80K
Budget/Appropriations, Medicare/Medicaid, Health Issues
1st Quarter (Jan 1 - Mar 31) 2026
- TIBER CREEK GROUP$80K
Health Issues, Foreign Relations, Defense, Medicare/Medicaid
2nd Quarter (Apr 1 - June 30) 2026
- TODD STRATEGY GROUP$80K
Health Issues, Medicare/Medicaid
2nd Quarter (Apr 1 - June 30) 2026
- TODD STRATEGY GROUP$80K
Medicare/Medicaid, Health Issues
1st Quarter (Jan 1 - Mar 31) 2026
Federal contracts
Largest awards of the last two years
- Department of Health and Human Services$6.1M
ASTRAZENECA PHARMACEUTICALS LP · from Aug 15, 2021
- Department of Defense$500
ASTRAZENECA PHARMACEUTICALS LP · from Nov 3, 2025
- Department of Defense$500
ASTRAZENECA PHARMACEUTICALS LP · from Oct 31, 2024
- Department of Health and Human Services$0
ASTRAZENECA PHARMACEUTICALS LP · from Jun 22, 2023
More on AZN
Who traded it
Most active first
Every disclosure
31 in total, newest first
Follow AstraZeneca PLC (AZN) by email
New trades in AstraZeneca PLC (AZN) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.